Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Parsons

Showing results (401-410 of 424) with videos related to

Pageof 43
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2007
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cellsD Eugene Redmond, Kimberly B Bjugstad, Yang D Teng, et al.
Cancer Research|April 23, 2009
eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survivalJeremy R Graff, Bruce W Konicek, Rebecca L Lynch, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Potent Kv1.3 inhibitors from correolide-modification of the C18 positionJianming Bao, Shouwu Miao, Frank Kayser, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockersSriram Tyagarajan, Prasun K Chakravarty, Bishan Zhou, et al.
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Science Advances|October 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Molecular Cancer Therapeutics|December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activityRobert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
A Pragmatic Guide to Establishing Clinical Decision Support Governance and Addressing Decision Support Fatigue: a Case StudyKensaku Kawamanto, Michael C Flynn, Polina Kukhareva, et al.
Pageof 43

Showing results (401-410 of 424) with videos related to

Sort By:
Pageof 43
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2007
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cellsD Eugene Redmond, Kimberly B Bjugstad, Yang D Teng, et al.
Cancer Research|April 23, 2009
eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survivalJeremy R Graff, Bruce W Konicek, Rebecca L Lynch, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Potent Kv1.3 inhibitors from correolide-modification of the C18 positionJianming Bao, Shouwu Miao, Frank Kayser, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockersSriram Tyagarajan, Prasun K Chakravarty, Bishan Zhou, et al.
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Science Advances|October 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Molecular Cancer Therapeutics|December 21, 2013
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activityRobert M Campbell, Bryan D Anderson, Nathan A Brooks, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
A Pragmatic Guide to Establishing Clinical Decision Support Governance and Addressing Decision Support Fatigue: a Case StudyKensaku Kawamanto, Michael C Flynn, Polina Kukhareva, et al.
Pageof 43